AKRO akerotx.com Earnings growth forecast for next year

Corporate emblem and logo of Akero (AKRO)

Earnings expectations for Akero Therapeutics (AKRO) rely on the work of elite scientists and the potential of new drugs. The projected net income trend demonstrates the impact of optimized biotechnological logistics and independence from macro cycles during the clinical testing period. The value of -11.30 determines this parameter level, capturing daily changes in analytical yield estimates for the company for the coming year.

Akero Therapeutics Inc (AKRO): Expected net earnings per share growth next year from 07/04/2022 to 12/20/2025

AKRO (Akero Therapeutics, Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Initial company analysis:AKRO, akerotx.com
Finished products of Akero

The commercialization prospects for liver metabolic disorder therapies directly determine current expectations for the EPS n+1 growth rate, reflecting the long-term sales potential of Akero Therapeutics (AKRO). This indicator measures the consensus forecast for earnings per share changes, allowing investors to assess the sensitivity of future capitalization to macroeconomic shifts and market conditions through the dynamics of expected net income.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year metsera.com MTSR|MoonLake Corp (MLTX) - Expected net earnings per share growth next year|CRNX - Net earnings per share growth forecast for next year|NAMS: Net earnings per share growth forecast for next year|SLNO: Earnings growth forecast for next year|FOLD - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year 89bio Pharma|Agios Corp (AGIO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year structuretx.com (GPCR)|Expected earnings per share growth for next year mimedx.com MDXG|Net earnings per share growth forecast for next year Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Net earnings per share growth forecast for next year|MBX: Expected earnings per share growth for next year|Altimmune Corp - Projected earnings per share increase next year|Aardvark Therapeutics Inc (AARD) - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Biomea Fusion (BMEA)|Earnings growth forecast for next year QNCX|Projected earnings per share increase next year GUTS|Earnings growth forecast for next year VTVT (vTv Therapeutics Inc.)|Expected earnings per share trend next year ATPC|Pluristem Therapeutics - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year synlogictx.com SYBX|LPCN: Earnings growth forecast for next year|Matinas BioPharma Holdings, Inc. - Expected earnings per share trend next year|SPRB (Spruce Biosciences Inc.) - Earnings growth forecast for next year|galecto.com (GLTO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year organovo.com ONVO|Radius Health (RDUS) - Expected net earnings per share growth next year